Alveron Pharma is Drug Discovery in Netherlands that focus on procoagulant cyclodextrins business. Founded in 2019. They cover business area such as developer, coagulation platform technology, cyclodextrin-base anticoagulant reversal drug, procoagulant cyclodextrin, excessive bleeding, hemophilia, trauma, surgery, coagulants-usage bleeding, medical practitioner, therapy, treatment, numerous type, thromboembolic disorder.
2019
( 5 years old in 2024 )
Procoagulant Cyclodextrins
-
Gasstraat 20
Kantoor 2.16
5349 AA Oss
Netherlands
Private
developercoagulation platform technologycyclodextrin-base anticoagulant reversal drugprocoagulant cyclodextrinexcessive bleedinghemophiliatraumasurgerycoagulants-usage bleedingmedical practitionertherapytreatmentnumerous typethromboembolic disorder
* We use standard office opening hours in near Alveron Pharma's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Alveron Pharma is Drug Discovery business from Netherlands that founded in 2019 (5 years old in 2024), Alveron Pharma business is focusing on Procoagulant Cyclodextrins.
Alveron Pharma headquarter office and corporate office address is located in Gasstraat 20 Kantoor 2.16 5349 AA Oss Netherlands.
Alveron Pharma was founded in Netherlands.
In 2024, Alveron Pharma is currently focus on procoagulant cyclodextrins sector.
Above is snippet of Google Trends for "procoagulant cyclodextrins" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Alveron Pharma, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
